Hookipa Pharma rises after posting higher full-year revenue
** Shares of therapy developer Hookipa Pharma HOOK.O rise
4.9% to 76 cents premarket
** Company's revenue for 12 months ended Dec. 31 at $20.1
mln vs $14.2 mln a year ago
** Hookipa has cash and cash equivalents of $117.5 mln as of
Dec. 31, 2023 vs compared with $113.4 mln as of Dec. 31, 2022
** Up to last close, stock down 10.6% YTD
(Reporting by Sneha S K in Bengaluru)
((Sneha.SK@thomsonreuters.com;))
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)